Annual Total Debt
$13.97 M
-$4.08 M-22.61%
December 31, 2023
Summary
- As of February 7, 2025, CTMX annual total debt is $13.97 million, with the most recent change of -$4.08 million (-22.61%) on December 31, 2023.
- During the last 3 years, CTMX annual total debt has fallen by -$10.90 million (-43.81%).
- CTMX annual total debt is now -49.52% below its all-time high of $27.68 million, reached on December 31, 2019.
Performance
CTMX Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$10.60 M
-$1.15 M-9.78%
September 30, 2024
Summary
- As of February 7, 2025, CTMX quarterly total debt is $10.60 million, with the most recent change of -$1.15 million (-9.78%) on September 30, 2024.
- Over the past year, CTMX quarterly total debt has dropped by -$4.46 million (-29.61%).
- CTMX quarterly total debt is now -64.14% below its all-time high of $29.55 million, reached on March 31, 2019.
Performance
CTMX Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
CTMX Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.6% | -29.6% |
| 3 y3 years | -43.8% | -29.6% |
| 5 y5 years | +100.0% | -29.6% |
CTMX Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -35.5% | at low | -51.1% | at low |
| 5 y | 5-year | -49.5% | at low | -61.7% | at low |
| alltime | all time | -49.5% | -100.0% | -64.1% | -100.0% |
CytomX Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $10.60 M(-9.8%) |
| Jun 2024 | - | $11.75 M(-8.7%) |
| Mar 2024 | - | $12.87 M(-7.9%) |
| Dec 2023 | $13.97 M(-22.6%) | $13.97 M(-7.2%) |
| Sep 2023 | - | $15.05 M(-6.4%) |
| Jun 2023 | - | $16.08 M(-5.9%) |
| Mar 2023 | - | $17.08 M(-5.4%) |
| Dec 2022 | $18.06 M(-16.7%) | $18.06 M(-5.0%) |
| Sep 2022 | - | $19.02 M(-4.5%) |
| Jun 2022 | - | $19.92 M(-4.3%) |
| Mar 2022 | - | $20.81 M(-4.0%) |
| Dec 2021 | $21.67 M(-12.9%) | $21.67 M(-3.8%) |
| Sep 2021 | - | $22.53 M(-3.4%) |
| Jun 2021 | - | $23.32 M(-3.2%) |
| Mar 2021 | - | $24.10 M(-3.1%) |
| Dec 2020 | $24.87 M(-10.2%) | $24.87 M(-2.9%) |
| Sep 2020 | - | $25.62 M(-2.7%) |
| Jun 2020 | - | $26.32 M(-2.5%) |
| Mar 2020 | - | $27.01 M(-2.4%) |
| Dec 2019 | $27.68 M | $27.68 M(-2.3%) |
| Sep 2019 | - | $28.34 M(-2.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $28.95 M(-2.0%) |
| Mar 2019 | - | $29.55 M(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(-100.0%) |
| Jun 2015 | - | $2.29 M(>+9900.0%) |
| Mar 2015 | - | $0.00(-100.0%) |
| Dec 2014 | $2.99 M(-28.9%) | $2.99 M(>+9900.0%) |
| Sep 2014 | - | $0.00 |
| Dec 2013 | $4.20 M | - |
FAQ
- What is CytomX Therapeutics annual total debt?
- What is the all time high annual total debt for CytomX Therapeutics?
- What is CytomX Therapeutics annual total debt year-on-year change?
- What is CytomX Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for CytomX Therapeutics?
- What is CytomX Therapeutics quarterly total debt year-on-year change?
What is CytomX Therapeutics annual total debt?
The current annual total debt of CTMX is $13.97 M
What is the all time high annual total debt for CytomX Therapeutics?
CytomX Therapeutics all-time high annual total debt is $27.68 M
What is CytomX Therapeutics annual total debt year-on-year change?
Over the past year, CTMX annual total debt has changed by -$4.08 M (-22.61%)
What is CytomX Therapeutics quarterly total debt?
The current quarterly total debt of CTMX is $10.60 M
What is the all time high quarterly total debt for CytomX Therapeutics?
CytomX Therapeutics all-time high quarterly total debt is $29.55 M
What is CytomX Therapeutics quarterly total debt year-on-year change?
Over the past year, CTMX quarterly total debt has changed by -$4.46 M (-29.61%)